FDA Orange Book · active-ingredient family
Streptomycin sulfate
Streptomycin sulfate is approved in 6 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
0
Brand (NDA)
6
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Generic (ANDA) products (6)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| STREPTOMYCIN SULFATE | XGEN PHARMS | ANDA 064210 | — | Jun 30, 1998 | |
| STREPTOMYCIN SULFATE | COPANOS | ANDA 060684 | — | Approved Prior to Jan 1, 1982 | |
| STREPTOMYCIN SULFATE×2 | LILLY | ANDA 060107 | — | Approved Prior to Jan 1, 1982 | |
| STREPTOMYCIN SULFATE | LILLY | ANDA 060404 | — | Approved Prior to Jan 1, 1982 | |
| STREPTOMYCIN SULFATE×2 | PFIZER | ANDA 060076 | — | Approved Prior to Jan 1, 1982 | |
| STREPTOMYCIN SULFATE | PFIZER | ANDA 060111 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Streptomycin sulfate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
